Reduction of postoperative blood loss by local administration of "4dryField PH" after duo-ear prosthesis implantation in patients with medial femoral neck fracture - a randomized controlled study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00017452

Enrollment

Registered

2019-06-11

Start date

2016-07-24

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

S72.01

Interventions

Group 1: - During the operation "4DryField®PH" is applied - The operation is performed according to the in-house-established scheme. There is no change regarding anesthesia, surgical access, surgical

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with medial femoral neck fracture (Garden type III / IV) who are indicated for the implantation of a hemiprosthesis according to the valid standard

Exclusion criteria

Exclusion criteria: - polytraumatized patients - presence of an injury to the ipsilateral limb - Patients with tumor disease - preoperative Hb <= 6 mmol / l - known starch allergy

Design outcomes

Primary

Measure	Time frame
check the effect of the local hemostyptic "4DryField®PH" on the postoperative blood loss after implantation of a duo head prosthesis with medial femoral neck fracture.	—

Secondary

Measure	Time frame
- Examination of the formation of a hematoma / seroma are examined sonographically - 6 weeks postoperatively, check the function of the operated hip joint by means of functional test	—

Countries

Germany

Contacts

Public ContactChristian Ribau

Universitätsklinik für Unfallchirurgie/Zenrale Notaufnahme

christian.ribau@med.ovgu.de+49-391-67-21293

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 24, 2026